| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |